Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

557 indexed citations
published 1996

Countries where authors are citing Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

Specialization
Citations

This map shows the geographic impact of Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis more than expected).

Fields of papers citing Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis.

About Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

This paper, published in 1996, received 557 indexed citations . Written by Alan F. Wahl, Karen Donaldson, Frank Lee, Scott A. Foster, G W Demers and Denise A. Galloway covering the research area of Oncology, Cancer Research and Cell Biology. It is primarily cited by scholars working on Oncology (389 citations), Molecular Biology (299 citations) and Cancer Research (124 citations). Published in Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm0196-72.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026